Sacrococcygeal teratoma classification: Difference between revisions
Line 16: | Line 16: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
''' | '''Type I''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Predominantly exterior; with minimal pelvic involvement | *Predominantly exterior; with minimal pelvic involvement | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
''' | '''Type II''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Predominantly external; with significant intrapelvic growth giving "hour-glass" appearance | *Predominantly external; with significant intrapelvic growth giving "hour-glass" appearance | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
''' | '''Type III''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Predominantly internal; withh intra-abdominal involvement | *Predominantly internal; withh intra-abdominal involvement | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
''' | '''Type IV''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Entirely pre-sacral; without external growth | *Entirely pre-sacral; without external growth |
Revision as of 14:14, 21 December 2015
Sacrococcygeal teratoma Microchapters |
Diagnosis |
---|
Echocardiography and Ultrasound |
Treatment |
Case Studies |
Sacrococcygeal teratoma classification On the Web |
American Roentgen Ray Society Images of Sacrococcygeal teratoma classification |
Risk calculators and risk factors for Sacrococcygeal teratoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Sacrococcygeal teratoma is classified into four different categories according to American Academy of Pediatrics Surgery classification based upon the anatomical location of the tumor.[1][2] Subtypes of sacrococcygeal teratoma have different staging systems based on the size and growth of the tumor, lymph node involvement, and the presence of metastasis.[3]
Classification
American Academy of Pediatrics Surgery Section System classifies Sacrococcygeal teratoma depending on the anatomical location of the tumor. [1][2]
Stage | Features |
---|---|
Type I |
|
Type II |
|
Type III |
|
Type IV |
|
Staging of Sacrococcygeal Teratoma
- I - Complete resection; negative tumor margins[3]
- II - Microscopic residuals; lymph node negative
- III - Lymph node involvement; Gross residual on biopsy; retroperitoneal node may be positive or negative
- IV - Distant metastasis may involve liver
Grade
According to Gonzalez-Crussi System, Sacrococcygeal teratoma is graded on a scale from 0-3, based on the histology:[2][4]
- Grade 0-Tumour contains only mature tissue.
- Grade 1-Tumour contains rare foci of immature tissues; <10%>
- Grade 2-Tumour contains moderate quantities of immature tissues.(10-50%)
- Grade 3-Tumour contains large quantities of immature tissue with or without malignant yolk sac elements.(>50%)
References
- ↑ 1.0 1.1 Puri P, Höllwarth ME. Pediatric Surgery, Diagnosis and Management. Springer Science & Business Media; 2009.
- ↑ 2.0 2.1 2.2 Myers LB, Bulich LA. Anesthesia for Fetal Intervention and Surgery. PMPH-USA; 2005.
- ↑ 3.0 3.1 DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's Cancer, Principles & Practice of Oncology. Lippincott Williams & Wilkins; 2008.
- ↑ Harms D, Zahn S, Göbel U, Schneider DT (2006). "Pathology and molecular biology of teratomas in childhood and adolescence". Klin Padiatr. 218 (6): 296–302. doi:10.1055/s-2006-942271. PMID 17080330.